![]() |
||||
|
||||
|
|
||||
Re: Sublingual Misoprostol for PPHFrom: Raymond Stephen (stephen.raymond@dhhs.tas.gov.au)Fri Sep 30 18:12:47 2005
This study requires a large pinch of salt - first, the study was misoprostol versus placebo; second, the improved PPH rate was not significant because the confidence limits straddle 1; third, the conclusion is only valid for loss of more than 1000 ml in a setting where you don't have oxytocin or ergometrine available. Steve -----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of art fougner, md Sent: Friday, 30 September 2005 10:50 PM To: Multiple recipients of list OB-GYN-L Subject: OB: Sublingual Misoprostol for PPH In this week's BMJ Sublingual misoprostol reduces the frequency of severe postpartum haemorrhage. BMJ 2005;331:723 (1 October), doi:10.1136/bmj.331.7519.723 art
-- art fougner, md
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Fri May 2 04:41:57 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.